SPI
NEUTRALSpire Healthcare Announces Holding Change
The healthcare provider has announced a change in shareholding, with FIL Limited increasing its stake in the company.
Spire Healthcare Group
170.40GBX
-0.93%
Market Cap
685.64M
Volume
1.94M
145% of avg
P/E Ratio
1460.91
EPS (TTM)
0.12
Beta
0.63
Day Range
168.80p - 174.00p
52 Week Range
164.00p170.40p256.50p
170.40p
Upcoming Events
1 August 2026
Maturity of extended banking facilities
31 December 2027
End of performance period for LTIP awards
SPI
NEUTRALSpire Healthcare Announces Holding Change
The healthcare provider has announced a change in shareholding, with FIL Limited increasing its stake in the company.
SPI
BADSpire Healthcare Warns of Profit at Lower End of Guidance
The healthcare provider warns that full-year profits will be at the lower end of expectations due to market conditions.
SPI
NEUTRALSpire Healthcare Evaluating Strategic Options
The healthcare provider is exploring strategic options, including a potential sale of the company.
SPI
NEUTRALSpire Healthcare Group Announces Director Dealings
The healthcare provider has announced changes to its major shareholders.
SPI
BADSpire Healthcare Reports Profit Slump Amid Challenging Market Conditions
The healthcare provider reported a significant drop in profits and earnings per share, despite modest revenue growth. Facing headwinds in both private and NHS markets, it anticipates continued challenges in the second half.
SPI
NEUTRALSpire Healthcare Appoints New Joint Corporate Broker
The healthcare provider has appointed Berenberg as a new joint corporate broker alongside its existing broker, J.P. Morgan Cazenove.
SPI
NEUTRALSpire Healthcare Announces Holding Changes
The healthcare provider has received a notification of changes in major shareholding positions.
SPI
NEUTRALSpire Healthcare Directors Exercise Sharesave Options
The healthcare provider announces its CEO and CFO have exercised Sharesave options, acquiring additional shares in the company.
SPI
NEUTRALSpire Healthcare Announces Regulatory Disclosure
The healthcare provider has made a regulatory disclosure regarding a change in major shareholding.